Twinlab Consolidated (TLCC) 10-Q 14 Nov 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 14, 2014
Document Information [Line Items]	'	'
Entity Registrant Name	'TWINLAB CONSOLIDATED HOLDINGS, INC.	'
Entity Central Index Key	'0001590695	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Trading Symbol	'TLCC	'
Entity Common Stock, Shares Outstanding	'	220,000,000
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash	$21	$300
Restricted cash	378	374
Marketable securities	38	60
Accounts receivable, net	4,860	6,282
Inventories, net	12,933	14,844
Prepaid expenses and other current assets	4,096	1,368
Total current assets	22,326	23,228
Property, plant and equipment, net	4,719	5,040
Intangible assets, net	7,681	8,032
Other assets	725	877
Total assets	35,451	37,177
Current liabilities:	'	'
Checks written in excess of cash	383	411
Accounts payable	9,626	8,127
Accrued expenses and other current liabilities	2,163	4,332
Current portion of long-term debt	13,017	75,422
Total current liabilities	25,189	88,292
Long-term liabilities:	'	'
Deferred gain on sale of assets	2,103	2,169
Long-term debt, net of current portion	9,012	22,651
Total long-term liabilities	11,115	24,820
Total liabilities	36,304	113,112
Commitments and contingencies	'	'
Stockholders' deficit:	'	'
Preferred stock, $0.001 par value, 500,000,000 shares authorized, no shares issued and outstanding	0	0
Common stock, $0.001 par value, 5,000,000,000 shares authorized, 220,000,000 and 200,000,000 shares issued and outstanding, respectively	220	200
Additional paid-in capital	179,595	90,165
Stock subscriptions receivable	-300	0
Accumulated deficit	-180,294	-166,248
Accumulated other comprehensive loss	-74	-52
Total stockholders' deficit	-853	-75,935
Total liabilities and stockholders' deficit	$35,451	$37,177

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Preferred stock, par value	$0.00	$0.00
Preferred Stock, Shares Authorized	500,000,000	500,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common stock, par value	$0.00	$0.00
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000
Common Stock, Shares, Issued	220,000,000	200,000,000
Common Stock, Shares, Outstanding	220,000,000	200,000,000

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net sales	$12,988	$19,571	$47,135	$57,265
Cost of sales	10,174	14,328	36,020	39,930
Gross profit	2,814	5,243	11,115	17,335
Selling, general and administrative expenses	7,866	5,283	19,768	18,225
Loss from operations	-5,052	-40	-8,653	-890
Other expense:	'	'	'	'
Interest expense, net	-2,644	-1,371	-5,368	-4,194
Realized gain on marketable securities	0	0	0	892
Other income, net	1	107	9	159
Total other expense	-2,643	-1,264	-5,359	-3,143
Loss before income taxes	-7,695	-1,304	-14,012	-4,033
Provision for income taxes	-14	-16	-34	-30
Net loss	-7,709	-1,320	-14,046	-4,063
Other comprehensive loss - unrealized loss on marketable securities	-9	-45	-22	-703
Total comprehensive loss	($7,718)	($1,365)	($14,068)	($4,766)
Weighted average number of common shares outstanding - basic and diluted (in shares)	336,121,692	43,542,956	355,506,995	43,542,956
Net loss per share - basic and diluted (in dollars per share)	($0.02)	($0.03)	($0.04)	($0.10)

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($14,046)	($4,063)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'
Depreciation and amortization	1,071	1,303
Amortization of debt discount	1,481	0
Non-cash interest on debt	2,678	450
Realized gain on marketable securities	0	-892
Changes in operating assets and liabilities:	'	'
Accounts receivable, net	1,422	804
Inventories, net	1,911	4,166
Prepaid expenses and other current assets and other assets	-2,786	-1,409
Checks written in excess of cash	-28	424
Accounts payable	1,292	160
Accrued expenses and other current liabilities	-1,296	69
Net cash provided by (used in) operating activities	-8,301	1,012
Cash flows from investing activities:	'	'
Proceeds from the sale of property, plant and equipment	0	7,305
Purchase of property, plant and equipment	-174	-393
Proceeds from the sale of marketable securities	0	892
Change in restricted cash	-4	309
Net cash provided by (used in) investing activities	-178	8,113
Cash flows from financing activities:	'	'
Net change in revolving credit facility	300	-3,084
Proceeds from the issuance of debt	11,541	2,000
Repayment of debt	-3,592	-7,521
Payment of financing costs	-81	-316
Proceeds from the issuance of common stock	40	0
Purchase and retirement of treasury stock	-8	0
Net cash provided by (used in) financing activities	8,200	-8,921
Net increase (decrease) in cash	-279	204
Cash at the beginning of the period	300	80
Cash at the end of the period	21	284
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	'	'
Cash paid for interest	2,647	2,707
Cash paid for income taxes	42	33
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING & FINANCING TRANSACTIONS	'	'
Deferred gain on sale of property, plant and equipment	0	2,282
Change in unrealized holding gain on marketable securities	22	703
Recorded debt discounts due to the issuance of warrants in connection with debt	$1,481	$0

NATURE_OF_OPERATIONS_AND_SUMMA

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Organization
	Twinlab Consolidated Holdings, Inc. (the “Company”) was incorporated on October 24, 2013 under the laws of the State of Nevada as Mirror Me, Inc. On August 7, 2014, the Company amended its articles of incorporation and changed its name to Twinlab Consolidated Holdings, Inc.
	Reverse Merger
	On September 4, 2014, the Company entered into an Agreement and Plan of Merger and entered into a First Amendment to Agreement and Plan of Merger on September 16, 2014 (as amended, the “Merger Agreement”), by and among the Company, TCC MERGER CO (“Sub Co”), a Delaware corporation and wholly-owned subsidiary of the Company, and Twinlab Consolidation Corporation (“TCC”), a Delaware corporation.  The Merger Agreement provided for the merger of Sub Co with and into TCC (the “Merger”), with TCC surviving the Merger as a wholly-owned subsidiary of the Company. The merger closed on September 16, 2014.
	The Merger is being accounted for as a reverse triangular merger.  TCC is the accounting acquirer for financial reporting purposes and the Company is the accounting acquiree.  Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the Merger are those of TCC and its subsidiaries and are recorded at the historical cost basis of TCC. The consolidated financial statements after completion of the Merger include the assets and liabilities of the Company and TCC, the operations of TCC and its subsidiaries, and the operations of the Company.
	Nature of Operations
	The Company and its subsidiaries manufacture and market high-quality, science-based nutritional supplements, and also provide health and wellness information. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, TCC, Twinlab Holdings, Inc. (“THI”), Twinlab Corporation (“Twinlab”) and ISI Brands, Inc. (“ISI”).
	Products include vitamins, minerals, specialty supplements and sports nutrition products primarily under the Twinlab® brand name (including the Twinlab® Fuel family of sports nutrition products); diet and energy products under the Metabolife® brand name; a line of products that promote joint health under the Trigosamine® brand name; and a full line of herbal teas under the Alvita® brand name. These products are sold primarily through health and natural food stores and national and regional drug store chains, supermarkets, and mass market retailers.
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
	Change in Fiscal Year
	Effective with the completion of the Merger, the Company changed its fiscal year to end on December 31.
	Basis of Presentation and Unaudited Information
	The condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with United States generally accepted accounting principles, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained therein. Financial results for any interim period are not necessarily indicative of financial results that may be expected for the fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s report on Form 8-K filed with the SEC on September 22, 2014.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserve for inventory obsolescence, recoverability of long-lived assets and estimated value of warrants.
	Significant Concentration of Credit Risk
	Sales to the Company’s top three major customers aggregated to approximately 27.8% and 30.3% of total sales for the nine months ended September 30, 2014 and 2013, respectively. Sales to one of those customers were approximately 13.9% and 15.3% of total sales in 2014 and 2013, respectively. Accounts receivable from these customers were approximately 28% and 27% of total accounts receivable as of September 30, 2014 and December 31, 2013, respectively.
	Geographic Concentrations
	Net revenues from customers residing in the following foreign countries were as follows for the nine months ended September 30, 2014 and September 30, 2013:
		September		% of Total			September		% of Total
		30, 2014		Revenues			30, 2013		Revenues
	Mexico	$	1,072		2.28	%	$	1,314		2.29	%
	Canada	$	1,966		4.17	%	$	1,213		2.12	%
	Other	$	4,767		10.11	%	$	9,658		16.86	%
	Fair Value of Financial Instruments
	The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
	Level 1 – inputs are quoted prices in active markets for identical assets that the reporting entity has the ability to access at the measurement date.
	Level 2 – inputs are other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly.
	Level 3 – inputs are unobservable inputs for the asset that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability.
	The following table summarizes the financial instruments of the Company measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013:
	September 30, 2014	Total		Level 1			Level 2		Level 3
	Marketable securities	$	38	$	38		$	-	$	-
	Total	$	38	$	38		$	-	$	-
	December 31, 2013	Total		Level 1			Level 2		Level 3
	Marketable securities	$	60	$	60		$	-	$	-
	Total	$	60	$	60		$	-	$	-
	Net Loss per Common Share
	The computation of basic net income (loss) per common share is based on the weighted average number of shares outstanding during the period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the period plus the weighted average common stock equivalents which would arise from the exercise of stock options, warrants and rights outstanding using the treasury stock method and the average market price per share during the period.
	For the three months and nine months ended September 30, 2014 and 2013, the diluted weighted average number of shares is the same as the basic weighted average number of shares as the inclusion of any common stock equivalents would be anti-dilutive.
	Recent Accounting Pronouncements
	In April 2014, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360)." ASU No. 2014-08 amends the requirements for reporting discontinued operations and requires additional disclosures about discontinued operations. Under the new guidance, only disposals representing a strategic shift in operations or that have a major effect on the Company's operations and financial results should be presented as discontinued operations. This new accounting guidance is effective for the Company’s fiscal year ending December 31, 2015, and may be applied retrospectively. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements.
	In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers.” This amended guidance will enhance the comparability of revenue recognition practices and will be applied to all contracts with customers. Expanded disclosures related to the nature, amount, timing, and uncertainty of revenue that is recognized are requirements under the amended guidance. This guidance will be effective for the Company’s fiscal year ending December 31, 2017 and may be applied retrospectively. The Company is currently evaluating the potential impact of adopting this guidance on its consolidated financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 310-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The amendments in this Update provide guidance in generally accepted accounting principles about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The Company is currently evaluating the potential impact of adopting this guidance on its consolidated financial statements.

GOING_CONCERN

GOING CONCERN	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Going Concern Disclosure [Text Block]	'
	NOTE 2 – GOING CONCERN
	The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. Since their formation, the Company and its subsidiaries have operated at a loss. At September 30, 2014, the Company had an accumulated deficit of $180,294 and a total stockholders’ deficit of $853. Through 2003, these losses were primarily associated with start-up activities and brand and infrastructure development. Since then, losses were primarily attributable to lower than planned sales resulting from high customer inventory positions at the beginning of the year, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs, and interest and refinancing charges associated with the Company’s debt refinancing. Losses have been funded primarily through issuance of preferred and common stock, borrowings from the Company’s stockholders, and third-party debt of which a significant amount has been personally guaranteed by certain of the Company’s stockholders.
	Because of this history of operating losses and significant interest expense on the Company’s debt, the Company has a working capital deficiency of $2,863 at September 30, 2014. The Company also has significant debt due within the next 12 months.
	Management continues to address and make significant progress with the operating issues; however, these continuing conditions raise substantial doubt about the Company's ability to continue as a going concern.
	Management has addressed operating issues through the following actions: focusing on growing the core business and brands, with international expansion; continuing emphasis on major customers and private label opportunities with major customers, key products and introducing new products; and reducing manufacturing and operating costs and continuing to negotiate lower prices from major suppliers. Management believes that it will be able to restructure the debt obligations that are currently due in 2014 to extend the due date to years subsequent to 2014; however, there can be no assurance that the Company will be able to restructure its existing debt obligations or meet its debt obligations as they become due. In connection with the Merger, management was able to convert a majority of the Company’s outstanding debt to equity. Additionally, management believes that by improving operations, continuing to focus on cost reductions, and restructuring debt payment obligations as discussed above, the Company will be able to fund operations over the next twelve months; however, there can be no assurance that the Company will be able to improve operations, reduce costs, or, as discussed above, restructure remaining debt obligations.
	The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

MERGER

MERGER	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	NOTE 3 – MERGER
	On September 4, 2014, the Company entered into the Merger Agreement.  The Merger Agreement provided for the Merger with TCC surviving the Merger as a wholly owned subsidiary of the Company. The Merger closed on September 16, 2014.
	Pursuant to the terms of the Merger, the Company issued 199,995,000 shares of restricted common stock in exchange for 100% of TCC’s issued and outstanding common and preferred stock. Total issued and outstanding common stock of the Company, after giving effect to the Merger, is 220,000,000 shares.
	As a result of the closing of the Merger, the Company has become a holding company and its main focus has been redirected to the operations of TCC.
	The Merger is being accounted for as a reverse triangular merger.  TCC is the accounting acquirer for financial reporting purposes and the Company is the accounting acquiree.  Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the Merger are those of TCC and are recorded at the historical cost basis of TCC. The consolidated financial statements after completion of the Merger include the assets and liabilities of the Company and TCC, the operations of TCC and its subsidiaries, and the operations of the Company.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	NOTE 4 – INVENTORIES
	Inventories consisted of the following at:
		September 30,		December 31,
		2014		2013
	Raw materials	$	4,571	$	5,302
	Work in process		1,598		2,023
	Finished goods		8,285		9,191
			14,454		16,516
	Reserve for obsolete inventory		-1,521		-1,672
		$	12,933	$	14,844

PROPERTY_AND_EQUIPMENT

PROPERTY AND EQUIPMENT	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	NOTE 5 – PROPERTY AND EQUIPMENT
	Property and equipment consisted of the following at:
		September 30,		December 31,
		2014		2013
	Machinery and equipment	$	10,013	$	10,007
	Computers and other		6,506		6,339
	Land		577		577
	Aquifer		2,855		2,855
	Leasehold improvements		1,515		1,514
			21,466		21,292
	Accumulated depreciation and amortization		-16,747		-16,252
		$	4,719	$	5,040
	Assets held under capital leases are included in machinery and equipment and amounted to $2,437 and $2,019 as of September 30, 2014 and December 31, 2013, respectively.
	Depreciation and amortization expense totaled $495 and $692 for the nine months ended September 30, 2014 and 2013, respectively. Depreciation and amortization expense totaled $114 and $228 for the three months ended September 30, 2014 and 2013, respectively.

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	NOTE 6 – INTANGIBLE ASSETS
	Intangible assets consisted of the following at:
		September 30,		December 31,
		2014		2013
	Trademarks	$	10,142	$	10,142
	Customer relationships		1,824		1,824
			11,966		11,966
	Accumulated amortization		-4,285		-3,934
		$	7,681	$	8,032
	Trademarks are amortized over a period of 30 years and customer relationships are amortized over a period of 16 years. Amortization expense was $351 and $325 for the nine months ended September 30, 2014 and 2013, respectively. Amortization expense was $127 and $216 for the three months ended September 30, 2014 and 2013, respectively.

LONGTERM_DEBT

LONG-TERM DEBT	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	NOTE 7 – LONG-TERM DEBT
	Long term-debt consisted of the following as of September 30, 2014 and December 31, 2013:
		September 30,		December 31,
		2014		2013
	Related-Party Debt: Notes payable to other entities owned or governed by stockholders which are unsecured, with interest rates ranging from LIBOR plus 2% (2.25% as of December 31, 2013) to 8%, maturing through December 31, 2017. One of the notes has provided full, unconditional, joint and several guarantees at a cost to the Company of $150 per quarter.	$	10,765	$	15,778
	Senior Credit Facility: Revolving $15,000 asset-based credit facility payable to a financial institution with an interest rate equal to LIBOR plus 6% (6.25% as of December 31, 2013), due on demand. The Company is required to pay an unused commitment fee of 0.75% per annum. Collateralized by a first priority lien on all of the assets of the Company. Certain stockholders have also personally guaranteed the Senior Credit Facility.		7,814		7,514
	Vendor Term Notes: Loans payable to vendors with rates ranging from 6% to 4.5% and maturing dates of November 2014 and May 2015.		1,013		-
	Capital Lease Obligations: Capital leases with rates ranging from 10.13% to 13.21% and maturing dates ranging from February 2014 to October 2016.		2,437		2,019
	Direct Stockholder Loans – extinguished in 2014		-		44,721
	Subordinated Bank Debt – extinguished in 2014		-		28,041
	Total		22,029		98,073
	Less current portion		-13,017		-75,422
	Long-term debt	$	9,012	$	22,651
	Certain of the long-term debt agreements require the Company to meet certain affirmative and negative covenants, including maintenance of specified ratios. In management’s opinion, the Company was in compliance with the covenants as of September 30, 2014.
	On August 7, 2014 and on September 16, 2014, in anticipation of and contemporaneously with the Merger, respectively, Twinlab entered into amendments of its revolving credit facility with Fifth Third Bank, which has a credit limit of $15,000, primarily for the purpose of obtaining the bank's consent to the Merger.  The line of credit is secured by all assets of the Company and its subsidiaries.  Each parent company of Twinlab, including the Company, TCC and THI and its sister company, ISI Brands, Inc., has guaranteed Twinlab’s obligations under the line of credit.
	On May 1, 2014, Twinlab borrowed $3,000 from an individual who is a related party, evidenced by an unsecured convertible promissory note due on January 31, 2015.  The interest rate was 10% per annum. On September 3, 2014, Twinlab entered into an assignment, assumption and conversion agreement with the individual to convert this debt.  On September 5, 2014, the note was converted into 1,477,833 shares of TCC common stock, which shares were subsequently exchanged for shares of the Company’s common stock in the Merger.  Accrued interest on the note will be paid to the payee in cash.
	On August 15, 2014, Twinlab borrowed $3,200 from an individual who is a related party, evidenced by an unsecured convertible promissory note due on January 31, 2015. The interest rate was 10% per annum. On September 5, 2014, Twinlab entered into a conversion agreement with the individual to convert this debt. On September 5, 2014, the note and accrued interest thereon were converted into 4,210,526 shares of TCC common stock, which shares were subsequently exchanged for shares of the Company’s common stock in the Merger.
	On September 3, 2014, Twinlab borrowed $2,800 from an individual who is a related party, evidenced by an unsecured convertible promissory note due on January 31, 2015.  The interest rate was 10% per annum. On September 5, 2014, Twinlab entered into a conversion agreement with the individual to convert this debt.  On September 5, 2014, the note and accrued interest thereon were converted into 3,684,211 shares of TCC common stock, which shares were subsequently exchanged for shares of the Company’s common stock in the Merger.
	On July 31, 2014, THI entered into a “Debt Repayment Agreement” with a related party pursuant to which the related party exchanged debt totaling approximately $90,000 in consideration of (i) the issuance by THI to such party of 7,000 shares of Series B cumulative preferred stock and THI’s undertaking to pay such party $4,900 per year in structured monthly payments for 3 years provided that such payment obligations will terminate at such earlier time as the trailing ninety day volume weighted average closing sales price of the Company on all domestic securities exchanges on which it is listed equals or exceeds $5.06 per share. The 7,000 shares of Series B preferred stock were subsequently exchanged for shares of the Company’s common stock in the Merger.

STOCKHOLDERS_DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	NOTE 8 – STOCKHOLDERS’ DEFICIT
	On May 1, 2014, the Company issued 20,000,000 shares of common stock for cash of $40 at a price of $0.002 per share.
	On August 28, 2014, the Company amended its Articles of Incorporation (the “Charter Amendment”) to effectuate a 50 to 1 forward split (the “Forward Split”) of its issued and unissued common and preferred shares as of September 9, 2014, the record date. As a consequence of the Forward Split, the issued and outstanding shares of common stock of the Company increased from 4,400,000 shares immediately prior to the Forward Split becoming effective to 220,000,000 shares following the Forward Split. The number of authorized common shares increased from 100,000,000 to 5,000,000,000 common shares.
	The Company’s authorized preferred stock increased from 10,000,000 shares to 500,000,000 shares.  No shares of the preferred stock have been issued.
	On September 16, 2014, the Company completed the Merger (see Note 3) and issued 199,995,000 shares of its common stock in exchange for 100% of TCC’s issued and outstanding common and preferred stock. Previously on September 16, 2014 and in anticipation of the Merger, the Company repurchased and retired 199,995,000 shares of its common stock for cash of $8. Additionally, the selling stockholder forgave debt of $7 and accrued interest of approximately $.3 and agreed to resign as an officer and director of the Company.
	In connection with the Merger, the Chief Executive Officer and President of the Company (the “CEO”) entered into a Subscription and Surrender Agreement with TCC, the benefit of which accrues to the Company, pursuant to which the CEO will contribute, for no consideration, up to 65,306,102 shares of the common stock received in the Merger he holds to facilitate acquisitions and the raising of capital by the Company, provide a pool of shares to be used for incentive awards by the Company and for use by the Company for other proper purposes, without such events diluting the interests of other shareholders.  The CEO also has a contingent agreement to acquire up to 5,021,834 shares of the Company’s outstanding common stock if either or both of the transactions subject to the option agreements discussed in Note 10 do not close.
	Pursuant to the Subscription and Surrender Agreement, the CEO acquired one share of TCC Series A Redeemable Preferred Stock in exchange for consideration of $200, which amount was receivable at September 30, 2014 and included in stock subscriptions receivable. The one share of Series A Preferred Stock was exchanged for shares of common stock of the Company in the Merger. The $200 stock subscription receivable was received subsequent to September 30, 2014 (See Note 11).
	Of the shares issued in the Merger, a total of 5,021,834 shares of common stock related to prior Securities Purchase Agreements whereby the investors acquired shares of common stock of TCC in exchange for promissory notes totaling $100. The subscription notes receivable bear interest at the rate of 5% per annum and mature on the date when proposed asset purchase agreements among certain affiliates of the investors are entered into.

WARRANTS_COMMON_STOCK_PUT_AGRE

WARRANTS, COMMON STOCK PUT AGREEMENT AND REGISTRATION RIGHTS AGREEMENT	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	NOTE 9 – WARRANTS, COMMON STOCK PUT AGREEMENT AND REGISTRATION RIGHTS AGREEMENT
	In connection with the September 3, 2014 debt agreement described in Note 7, TCC issued to the lender a warrant to acquire 5,592,105 shares of TCC common stock at a purchase price of $0.76 per share, which warrant was assumed by the Company in connection with the Merger and is now exercisable into shares of the Company’s common stock.
	The Company issued a Series A Warrant (the “First Warrant”) to Capstone Financial Group, Inc. (“Capstone”), effective as of September 30, 2014. Pursuant to the First Warrant, Capstone has the right to purchase up to 52,631,579 shares of Common Stock at an exercise price of $0.76 per share. The First Warrant is exercisable from October 1, 2014 through October 31, 2017. The First Warrant provides for equitable adjustments in the event of a stock split, stock dividend, reclassification, consolidation or merger. The Company has agreed with Capstone that if the Company issues a security (i) exercisable or exchangeable for or (ii) convertible into shares of Common Stock at a date after October 1, 2014 and such security provides for anti-dilution protection, the shares of Common Stock issuable under the First Warrant shall enjoy the same anti-dilution protection as that first issued security.
	The Company also issued a Series B Warrant (the “Second Warrant”) to Capstone, effective as of September 30, 2014. Pursuant to the Second Warrant, Capstone has the right to purchase up to 22,368,421 shares of Common Stock at an exercise price of $0.76 per share. The Second Warrant is exercisable from October 1, 2014 through October 31, 2017 but only to the extent and in the same proportions as exercises by Capstone of the First Warrant. The Second Warrant provides for equitable adjustments in the event of a stock split, stock dividend, reclassification, consolidation or merger. The Company has agreed with Capstone that if the Company issues a security (i) exercisable or exchangeable for or (ii) convertible into shares of Common Stock at a date after October 1, 2014 and such security provides for anti-dilution protection, the shares of Common Stock issuable under the Second Warrant shall enjoy the same anti-dilution protection as that first issued security.
	The Company and Capstone entered into a Common Stock Put Agreement, dated as of September 30, 2014 (the “Put Agreement”). Pursuant to the Put Agreement, Capstone indicated its intent to exercise the First Warrant at a rate of no less than 1,461,988 shares of Common Stock (the “Minimum Amount”) per month over the term of the First Warrant (the “Minimum Rate”). In the event that Capstone does not exercise the First Warrant by November 15, 2014 or any subsequent Periodic Exercise Date (as defined in the Put Agreement) such that as of the applicable Exercise Date, Capstone’s cumulative purchases of Common Stock pursuant to the First Warrant has not been at a rate that is equal to or in excess of the Minimum Rate, then the Company has the right to notify Capstone not earlier than 30 days and not later than 40 days after the applicable Exercise Date of the Company’s exercise of its put rights under the Put Agreement (the “Put Notice”). Upon receipt of the Put Notice, Capstone is required to exercise the First Warrant to (i) purchase the Minimum Amount by a date identified in the Put Notice that is no earlier than 10 days after and no later than 30 days after the date of the Put Notice (the “Put Date”), or if Capstone has previously exercised the First Warrant to purchase shares in excess of the Minimum Rate, then such lesser amount of Common Stock as would, if purchased as of the applicable Exercise Date, have made Capstone’s purchases of Common Stock pursuant to the First Warrant as of such Exercise Date equal to the Minimum Rate (the “Initial Mandatory Purchase”) and (ii) purchase by a date that is no later than each subsequent Periodic Exercise Date an amount of Common Stock such that as of each such Periodic Exercise Date, Capstone’s cumulative purchases of Common Stock pursuant to the First Warrant through that date has been at a rate that is no less than the Minimum Rate (the “Periodic Mandatory Purchases”). Following delivery of the Put Notice by the Company, Capstone’s failure to make the Initial Mandatory Purchase by the Put Date shall be an “Event of Default”. Following the delivery of the Put Notice by the Company, Capstone’s failure to make when due any Periodic Mandatory Purchase is a breach of the Put Agreement, and if such breach is not timely cured by Capstone, such uncured breach shall be deemed an Event of Default. Upon the occurrence of an Event of Default as described above, (i) Capstone’s right to purchase all shares of Common Stock remaining unpurchased under the First Warrant is converted into an obligation, accelerated and immediately due and (ii) the Second Warrant immediately terminates as to any shares of Common Stock remaining exercisable under the Second Warrant. In the event the Company invokes its right pursuant to the Put Notice to require Capstone to exercise the First Warrant, the purchase price per share of Common Stock thereunder is $0.775 per share. In the event that the Company converts and accelerates Capstone’s obligations to purchase the shares of Common Stock remaining unexercised under the First Warrant, Capstone has the right to surrender issued and outstanding shares of Common Stock to the Company to be credited towards Capstone’s obligations, with such surrendered shares valued at $0.76 per share of Common Stock.
	The Company and Capstone entered into a Registration Rights Agreement, dated as of September 30, 2014 (the “Registration Agreement”). Pursuant to the Registration Agreement, Capstone can require the Company to register the shares of Common Stock acquired upon exercise of the First Warrant and the Second Warrant at such time as the Company is eligible to register securities on a Registration Statement on Form S-3 and thereafter file additional registration statements if requested by Capstone on a quarterly basis. The Registration Agreement contains terms and conditions customary for the grant of registration rights.
	A summary of the status of the warrants issued by the Company as of September 30, 2014, and changes during the nine months then ended is presented below:
				Weighted
				Average
		Shares		Exercise Price
	Outstanding, December 31, 2013		-	$	-
	Granted		80,592,105	$	0.76
	Canceled / Expired		-	$	-
	Exercised		-	$	-
	Outstanding, September 30, 2014		80,592,105	$	0.76

OPTION_AGREEMENTS

OPTION AGREEMENTS	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Combination, Option Agreements Disclosure [Text Block]	'
	NOTE 10 – OPTION AGREEMENTS
	In September 2014, TCC entered into an option agreement ("Option No. 1") that gives TCC an exclusive option to purchase 100% of the equity of a marketer and distributor of nutritional products (“Target No. 1”) on certain agreed upon terms.  TCC paid $2,000 to acquire Option No. 1, which is represented within the prepaid expenses and other current assets line item in the accompanying consolidated balance sheet dated September 30, 2014.  Option No. 1 can be exercised on or before July 13, 2015.  As an option, the Company will have the right, but not the obligation, to acquire the equity of Target No. 1 for a purchase price of $37,000, payable in cash at the closing of the acquisition without reduction for the option purchase price.  At present none of the Company, TCC or any other subsidiary of the Company has sufficient funds necessary to close on the acquisition of the equity of Target No. 1, if it were to exercise Option No. 1.  The Company believes that it and TCC will be able to raise the necessary funds to exercise Option No. 1 on a timely basis, although there can be no assurance that the Company and TCC will be successful.
	In September 2014, TCC entered into an option agreement (“Option No. 2”) that gives TCC an exclusive option to purchase substantially all of the assets and assume certain operating liabilities of a manufacturer of nutritional products on certain agreed upon terms (“Target No. 2”).  TCC agreed to pay $350 to acquire Option No. 2, which is represented within the prepaid expenses and other current assets line item in the accompanying consolidated balance sheet dated September 30, 2014.  Option No. 2 can be exercised on or before December 13, 2014.  As an option, TCC has the right, but not the obligation, to acquire the assets of Target No. 2, for a purchase price of $10,500, payable in cash at the closing of the acquisition.  The purchase price for the assets of Target No. 2 would not be reduced by the option purchase price.  If the Company does not exercise Option No. 2 within the exercise period, it will pay the grantor break-up fees of approximately $400.  At present none of the Company, TCC or any other subsidiary of the Company has sufficient funds necessary to close on the acquisition of the assets of Target No. 2, if it were to exercise the option.  The Company believes that it and TCC will be able to raise the necessary funds to exercise Option No. 2 on a timely basis, although there can be no assurance that the Company and TCC will be successful.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	NOTE 11 – SUBSEQUENT EVENTS
	Subsequent to September 30, 2014, $200 of the stock subscriptions receivable discussed in Note 8 was received.
	On November 13, 2014, the Company, TCC, THI, ISI and Twinlab (the Company, TCC, THI and ISI collectively, the “Twinlab Companies”), entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”) with Penta Mezzanine SBIC Fund I, L.P. (“Penta”).
	Pursuant to the Purchase Agreement, Penta purchased from the Twinlab Companies (i) a note in the amount of $8,000 (the “Initial Note”) and (ii) a warrant exercisable for an aggregate of 4,091,122 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Initial Warrant”).
	The Initial Note matures on November 13, 2019 (the “Maturity Date”). Payments of principal are due on a quarterly basis commencing November 13, 2017 in installments of (i) $360 per quarter for the first four quarters, (ii) $440 per quarter for the next for quarters and (iii) $520 per quarter for each quarter thereafter. The Initial Note bears interest at a rate of twelve percent (12%) per year (“Interest”). Interest is payable monthly, commencing on November 30, 2014. Following an Event of Default (as defined in the Purchase Agreement) and after the Maturity Date, the rate of interest will be increased to eighteen percent (18%) per year. Amounts outstanding under the Initial Note may be prepaid, in whole or in part at any time, with prepayment fees ranging from three percent (3%) to one percent (1%) depending on when the prepayment is made. No prepayment fee is due for prepayments made after November 13, 2017.
	The Twinlab Companies were required to pay certain fees and expenses in connection with the sale of the Initial Note and Initial Warrant, including (i) legal fees incurred by Penta in connection with the Purchase Agreement and the transactions contemplated by such Agreement and (ii) a fee of $160.
	The Purchase Agreement provides that the Twinlab Companies shall use the proceeds of Notes and Warrants solely to (a) pay a portion of the consideration for the acquisition of substantially all the assets of a manufacturer of nutritional products (as described as “Target No. 2” in the Company’s Report on Form 8-K, filed with the Securities and Exchange Commission on September 22, 2014 under the caption “ Management’s Discussion and Analysis of Financial Condition and Results of Operation – Overview and Outlook – Recent Developments”), (b) pay costs relating to the closing of the transactions contemplated by the Purchase Agreement and the closing of the Deferred Draw Note and the Target 2 Acquisition, (c) for working capital and general corporate purposes, or (d) to pay down the revolving loan under the Credit Agreement (as defined below) which can be re-drawn (subject to the limitations set forth in the Credit Agreement) for any of the foregoing.
	Pursuant to the Purchase Agreement, the Twinlab Companies granted Penta a security interest (the “Security Interest”) in and lien on its assets as security for the Penta Obligations (as defined in the Purchase Agreement). The Security Interest is evidenced by a Security Agreement, dated as of November 13, 2014, by and among the Twinlab Companies and Penta.
	In addition, the Company pledged the shares it owns in each of TCC, THI, ISI and Twinlab as security for the Penta Obligations.
	Penta also agreed to purchase from the Twinlab Companies, not later than November 13, 2015, an additional note in the amount of $2,000 (the “Deferred Draw Note”). The terms of the Deferred Draw Note are the same as the Initial Note except that (a) payments of principal are due in installments of (i) $90 per quarter for the first four quarters, (ii) $110 per quarter for the next four quarters and (iii) $130 per quarter for each quarter thereafter and (b) the first interest payment date is as of this date undeterminable. The Company will issue Penta a warrant (the “Deferred Warrant”) to purchase 4,960,740 shares of Common Stock (reduced by the number of shares of Common Stock previously acquired by Penta upon exercise of the Initial Warrant) at the time the Deferred Draw Note is issued to Penta. The Initial Warrant will be canceled and replaced in its entirety by the Deferred Warrant upon issuance of the Deferred Warrant. The terms of the Deferred Warrant are the same as the Initial Warrant.
	The Twinlab Companies will pay certain fees and expenses in connection with the sale of the Deferred Draw Note, including a fee to Penta of $40.
	The Purchase Agreement contains terms and conditions customary for a transaction of this nature including, without limitation, (i) furnishing of reports and financial information; (ii) obtaining key-person life insurance on the life of the chief executive officer and/or president of the Twinlab Companies; (iii) electing a representative of Penta to serve on the Board of Directors of the Company until the earlier of (x) the date on which less than $5,000 of principal remains outstanding under the Notes or (y) the date on which the Company has a market cap of $400,000 or more and EBITDA (as defined in the Purchase Agreement) for the four fiscal quarters then ending of greater than or equal to $20,000, (iv) meeting certain financial tests as to the Minimum Adjusted EBITDA, Fixed Charge Coverage Ratio and Total Funded Debt to Adjusted EBITDA Ratio, all as defined in the Purchase Agreement; (v) restrictions on certain mergers, consolidations, asset sales and acquisitions; (vi) restrictions on the making of capital expenditures in any fiscal year in excess of $2,500; (vii) restrictions on the making of dividends; (viii) restrictions on incurring indebtedness and (ix) restrictions on certain asset dispositions.
	Pursuant to the Initial Warrant, Penta has the right to acquire 4,091,122 shares of Common Stock, subject to certain adjustments, at a purchase price of $0.01 in the aggregate, at any time prior to November 13, 2019.
	In addition to adjustments on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and sale of all or substantially all of the Company’s assets or property, the number of shares of Common Stock issuable pursuant to the Initial Warrant shall be increased in the event the Company’s and its Subsidiaries’ (as defined in the Initial Warrant) audited Adjusted EBITDA (as defined in the Initial Warrant) for the fiscal year ending December 31, 2018 does not equal or exceed $19,250.
	The Company has granted Penta certain registration rights, commencing October 1, 2015, for the shares of Common Stock issuable on exercise of the Initial Warrant.
	At any time during the period beginning after the occurrence of a Put Event and ending on November 13, 2019, Penta may (or, in the case of clause (e) of the definition of Put Event below, Penta shall) require the Company to purchase all or any portion of the equity interest in the Company issued or represented by the Initial Warrant (the “Equity Interest”) at the Put Price. “Put Event” means any of the following: (a) the date that 70% or more of all interest, principal and other expense obligations due to Penta under the Purchase Agreement and/or the Note are satisfied in full by the Company; provided, however, that if such interest, principal and other expense obligations have been satisfied solely as a result of the payment of insurance proceeds in connection with the key-person life insurance policy (or any substitution or replacement thereof) contemplated by Section 5.3 of the Purchase Agreement, this clause (a) shall only be a Put Event upon the earlier of (i) one (1) year following such payment or (ii) the Maturity Date; (b) the occurrence of a Change in Control (as defined in the Purchase Agreement); (c) a material breach by the Company of its obligations under this Warrant or the Purchase Agreement; provided, however, that 180 days after either (i) a cure of the material breach by the Company or (ii) a waiver by Penta of such material breach shall cease to be a Put Event; (d) an Event of Default (as defined in the Purchase Agreement) not otherwise cured or waived in accordance with the terms of the Purchase Agreement; (e) the date Penta elects to increase the Put Price in accordance with the definition of "Put Price"; or (f) the Maturity Date. “Put Price” means an amount equal to the greater of: (i) the product of: (x) ten (10) times the Company’s and its Subsidiaries’ audited Adjusted EBITDA (on a consolidated basis) with respect to the twelve (12) months immediately preceding the date of the Put Notice, times (y) Penta’s percentage ownership in the Company on a Fully-Diluted Basis (as defined in the Initial Warrant) as of the date of the Put Notice assuming the full exercise of the remaining Warrant (the “Holder’s Percentage”); or (ii) the Fair Market Value of the Current Holder’s Equity Interests (as defined in the Initial Warrant) underlying the Initial Warrant.
	Solely for the purposes of determining the Put Price, in the event that both (a) the Company’s and its Subsidiaries’ audited Adjusted EBITDA (or if unavailable, the reviewed Adjusted EBITDA) for the twelve trailing months for the quarter-end immediately preceding the Put Closing, as described in the Initial Warrant does not equal or exceed the Target EBITDA (as defined in the Purchase Agreement), and (b) 70% or more of all interest, principal and other expense obligations due to Penta under the Purchase Agreement and/or the Notes are satisfied in full by the Company, then, solely for the purposes of determining the “Holder’s Percentage” as set forth in clause (y) of the definition of “Put Price” above and as applied in calculating such Put Price, Penta may elect to have the Current Holder’s Equity Interest deemed to increase (but not decrease) by a percentage equal to the Conversion Ratio.
	In the event that Penta requires the Company to repurchase the Equity Interest and (i) funds are not legally available to the Company to fully do so, the Company shall purchase pro rata and the balance of the amount due shall be added to the principal of the Initial Note or (ii) the Company is unable in accordance with applicable law to purchase all of the Initial Warrant and or Equity Interest, the Company will if so requested by Penta, (i) purchase in accordance with the Put Notice the maximum number of such put Warrants and/or Equity Interest underlying same which the Company may purchase and (ii) in one or more installments, at the earliest time that the Company may lawfully do so, purchase all remaining put Warrants and/or Equity Interest underlying same and pay interest at the rate of 15% (or the maximum rate of interest permitted by law) per annum on the amount of the aggregate Put Price attributable to such remaining Warrants and/or Equity Interest underlying same from the Put Closing (as defined in the Initial Warrant) to the date on which such amount is paid in full; provided, however, that, to the extent the Company is unable to pay such amount or a portion thereof, such amount or a portion thereof, as applicable, will be added to the principal of the Initial Note. In the event that, based on the values of the Company's assets and liabilities reflected in the books and records of the Company, it would be unlawful, under applicable state laws, for it to purchase Warrants and/or the Equity Interest underlying same, or pay the Put Price therefor, the Company agreed, if and to the extent permitted by borrowing agreements of the Company then in place and applicable law, to revalue its assets and liabilities based upon their current fair market value, and to take such other action as may be necessary, to cause such purchase to no longer be unlawful.
	At any time during the period beginning after the occurrence of a Call Event and ending on November 13, 2019, the Company may require Penta to sell all or any portion of its Equity Interest (issued or represented by the Initial Warrant) at a price equal to the Call Price. A Call Notice may not be given if Penta has previously provided the Company with a Put Notice. “Call Event” shall mean any of the following: (a) the date that 70% or more of all interest, principal and other expense obligations due to Penta under the Purchase Agreement and/or the Note are satisfied in full by the Company; (b) the occurrence of a Change in Control; (c) the Maturity Date. “Call Price” shall mean an amount equal to the greater of: (i) the product of: (x) eleven (11) times the Company’s and its Subsidiaries’ audited Adjusted EBITDA (on a consolidated basis) with respect to the twelve (12) months immediately preceding the date of the Call Notice, times (y) Penta’s percentage ownership in the Company on a Fully-Diluted Basis as of the date of the Call Notice assuming the full exercise of the remaining Warrant; or (ii) the Fair Market Value of the Equity Interests underlying the Initial Warrant; or (iii) $3,750.
	Pursuant to a Subordination Agreement, dated as of November 13, 2014, by and between Penta and Fifth Third Bank (“FTB”), amounts owed by the Twinlab Companies to Penta are subordinate to amounts owed FTB pursuant to the Credit Agreement (as defined below).
	On November 13, 2014, Twinlab, THI and FTB entered into a Fifteenth Amendment to Credit Agreement (the “Amendment”). The Amendment amends the Credit Agreement, dated as of January 7, 2008, by and among Twinlab, THI and FTB, as previously amended (the “Credit Agreement”). Pursuant to the Amendment, FTB (i) consented to the Twinlab Companies’ transactions described above with Penta (the “Penta Transaction”); (ii) consented to potential sale/leaseback transactions between Twinlab and an equipment vendor; (iii) decreased the maximum revolving loan commitment under the Credit Agreement from $15,000 to $9,500; and (iv) made certain other amendments to the Credit Agreement.
	The Amendment requires that Twinlab apply the proceeds of the Penta Transaction (i) first to the costs and expenses of the Penta Transaction, (ii) second, as a non-permanent paydown to the then outstanding principal balance of the revolving loan made pursuant to the Credit Agreement, and (iii) third, in repayment of any of the other FTB Obligations (as defined in the Credit Agreement) then due and payable.
	FTB’s consent to the proposed sale/leaseback transaction is conditioned upon the receipt of net proceeds from such sale/leaseback transaction of not less than $2,500 on or before December 31, 2014. The Amendment requires that Twinlab apply the proceeds of the sale/leaseback transaction (i) first, to the costs and expenses arising from the sale/leaseback transaction, (ii) second, as a non-permanent paydown to the then outstanding principal balance of the revolving loan made pursuant to the Credit Agreement and (iii) third, in repayment of any of the other FTB Obligations then due and payable. Twinlab also must implement an equipment sale reserve of $1,250.
	Twinlab paid FTB an aggregate of $35 in fees in connection with the Amendment. In addition, unless the FTB Obligations are paid and satisfied in full and the Credit Agreement is terminated on or before December 31, 2014, Twinlab must pay FTB a fee of $100 on December 31, 2014.

NATURE_OF_OPERATIONS_AND_SUMMA1

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Organization [Policy Text Block]	'
	Organization
	Twinlab Consolidated Holdings, Inc. (the “Company”) was incorporated on October 24, 2013 under the laws of the State of Nevada as Mirror Me, Inc. On August 7, 2014, the Company amended its articles of incorporation and changed its name to Twinlab Consolidated Holdings, Inc.
Reverse Merger [Policy Text Block]	'
	Reverse Merger
	On September 4, 2014, the Company entered into an Agreement and Plan of Merger and entered into a First Amendment to Agreement and Plan of Merger on September 16, 2014 (as amended, the “Merger Agreement”), by and among the Company, TCC MERGER CO (“Sub Co”), a Delaware corporation and wholly-owned subsidiary of the Company, and Twinlab Consolidation Corporation (“TCC”), a Delaware corporation.  The Merger Agreement provided for the merger of Sub Co with and into TCC (the “Merger”), with TCC surviving the Merger as a wholly-owned subsidiary of the Company. The merger closed on September 16, 2014.
	The Merger is being accounted for as a reverse triangular merger.  TCC is the accounting acquirer for financial reporting purposes and the Company is the accounting acquiree.  Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the Merger are those of TCC and its subsidiaries and are recorded at the historical cost basis of TCC. The consolidated financial statements after completion of the Merger include the assets and liabilities of the Company and TCC, the operations of TCC and its subsidiaries, and the operations of the Company.
Nature Of Operations [Policy Text Block]	'
	Nature of Operations
	The Company and its subsidiaries manufacture and market high-quality, science-based nutritional supplements, and also provide health and wellness information. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, TCC, Twinlab Holdings, Inc. (“THI”), Twinlab Corporation (“Twinlab”) and ISI Brands, Inc. (“ISI”).
	Products include vitamins, minerals, specialty supplements and sports nutrition products primarily under the Twinlab® brand name (including the Twinlab® Fuel family of sports nutrition products); diet and energy products under the Metabolife® brand name; a line of products that promote joint health under the Trigosamine® brand name; and a full line of herbal teas under the Alvita® brand name. These products are sold primarily through health and natural food stores and national and regional drug store chains, supermarkets, and mass market retailers.
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Fiscal Period, Policy [Policy Text Block]	'
	Change in Fiscal Year
	Effective with the completion of the Merger, the Company changed its fiscal year to end on December 31.
Basis of Accounting, Policy [Policy Text Block]	'
	Basis of Presentation and Unaudited Information
	The condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with United States generally accepted accounting principles, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained therein. Financial results for any interim period are not necessarily indicative of financial results that may be expected for the fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s report on Form 8-K filed with the SEC on September 22, 2014.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserve for inventory obsolescence, recoverability of long-lived assets and estimated value of warrants.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Significant Concentration of Credit Risk
	Sales to the Company’s top three major customers aggregated to approximately 27.8% and 30.3% of total sales for the nine months ended September 30, 2014 and 2013, respectively. Sales to one of those customers were approximately 13.9% and 15.3% of total sales in 2014 and 2013, respectively. Accounts receivable from these customers were approximately 28% and 27% of total accounts receivable as of September 30, 2014 and December 31, 2013, respectively.
Segment Reporting, Policy [Policy Text Block]	'
	Geographic Concentrations
	Net revenues from customers residing in the following foreign countries were as follows for the nine months ended September 30, 2014 and September 30, 2013:
		September		% of Total			September		% of Total
		30, 2014		Revenues			30, 2013		Revenues
	Mexico	$	1,072		2.28	%	$	1,314		2.29	%
	Canada	$	1,966		4.17	%	$	1,213		2.12	%
	Other	$	4,767		10.11	%	$	9,658		16.86	%
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair Value of Financial Instruments
	The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
	Level 1 – inputs are quoted prices in active markets for identical assets that the reporting entity has the ability to access at the measurement date.
	Level 2 – inputs are other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly.
	Level 3 – inputs are unobservable inputs for the asset that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability.
	The following table summarizes the financial instruments of the Company measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013:
	September 30, 2014	Total		Level 1			Level 2		Level 3
	Marketable securities	$	38	$	38		$	-	$	-
	Total	$	38	$	38		$	-	$	-
	December 31, 2013	Total		Level 1			Level 2		Level 3
	Marketable securities	$	60	$	60		$	-	$	-
	Total	$	60	$	60		$	-	$	-
Earnings Per Share, Policy [Policy Text Block]	'
	Net Loss per Common Share
	The computation of basic net income (loss) per common share is based on the weighted average number of shares outstanding during the period. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the period plus the weighted average common stock equivalents which would arise from the exercise of stock options, warrants and rights outstanding using the treasury stock method and the average market price per share during the period.
	For the three months and nine months ended September 30, 2014 and 2013, the diluted weighted average number of shares is the same as the basic weighted average number of shares as the inclusion of any common stock equivalents would be anti-dilutive.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent Accounting Pronouncements
	In April 2014, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360)." ASU No. 2014-08 amends the requirements for reporting discontinued operations and requires additional disclosures about discontinued operations. Under the new guidance, only disposals representing a strategic shift in operations or that have a major effect on the Company's operations and financial results should be presented as discontinued operations. This new accounting guidance is effective for the Company’s fiscal year ending December 31, 2015, and may be applied retrospectively. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements.
	In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers.” This amended guidance will enhance the comparability of revenue recognition practices and will be applied to all contracts with customers. Expanded disclosures related to the nature, amount, timing, and uncertainty of revenue that is recognized are requirements under the amended guidance. This guidance will be effective for the Company’s fiscal year ending December 31, 2017 and may be applied retrospectively. The Company is currently evaluating the potential impact of adopting this guidance on its consolidated financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 310-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The amendments in this Update provide guidance in generally accepted accounting principles about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The Company is currently evaluating the potential impact of adopting this guidance on its consolidated financial statements.

NATURE_OF_OPERATIONS_AND_SUMMA2

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	Net revenues from customers residing in the following foreign countries were as follows for the nine months ended September 30, 2014 and September 30, 2013:
		September		% of Total			September		% of Total
		30, 2014		Revenues			30, 2013		Revenues
	Mexico	$	1,072		2.28	%	$	1,314		2.29	%
	Canada	$	1,966		4.17	%	$	1,213		2.12	%
	Other	$	4,767		10.11	%	$	9,658		16.86	%
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	'
	The following table summarizes the financial instruments of the Company measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013:
	September 30, 2014	Total		Level 1			Level 2		Level 3
	Marketable securities	$	38	$	38		$	-	$	-
	Total	$	38	$	38		$	-	$	-
	December 31, 2013	Total		Level 1			Level 2		Level 3
	Marketable securities	$	60	$	60		$	-	$	-
	Total	$	60	$	60		$	-	$	-

INVENTORIES_Tables

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
	Inventories consisted of the following at:
		September 30,		December 31,
		2014		2013
	Raw materials	$	4,571	$	5,302
	Work in process		1,598		2,023
	Finished goods		8,285		9,191
			14,454		16,516
	Reserve for obsolete inventory		-1,521		-1,672
		$	12,933	$	14,844

PROPERTY_AND_EQUIPMENT_Tables

PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
	Property and equipment consisted of the following at:
		September 30,		December 31,
		2014		2013
	Machinery and equipment	$	10,013	$	10,007
	Computers and other		6,506		6,339
	Land		577		577
	Aquifer		2,855		2,855
	Leasehold improvements		1,515		1,514
			21,466		21,292
	Accumulated depreciation and amortization		-16,747		-16,252
		$	4,719	$	5,040

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
	Intangible assets consisted of the following at:
		September 30,		December 31,
		2014		2013
	Trademarks	$	10,142	$	10,142
	Customer relationships		1,824		1,824
			11,966		11,966
	Accumulated amortization		-4,285		-3,934
		$	7,681	$	8,032

LONGTERM_DEBT_Tables

LONG-TERM DEBT (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
	Long term-debt consisted of the following as of September 30, 2014 and December 31, 2013:
		September 30,		December 31,
		2014		2013
	Related-Party Debt: Notes payable to other entities owned or governed by stockholders which are unsecured, with interest rates ranging from LIBOR plus 2% (2.25% as of December 31, 2013) to 8%, maturing through December 31, 2017. One of the notes has provided full, unconditional, joint and several guarantees at a cost to the Company of $150 per quarter.	$	10,765	$	15,778
	Senior Credit Facility: Revolving $15,000 asset-based credit facility payable to a financial institution with an interest rate equal to LIBOR plus 6% (6.25% as of December 31, 2013), due on demand. The Company is required to pay an unused commitment fee of 0.75% per annum. Collateralized by a first priority lien on all of the assets of the Company. Certain stockholders have also personally guaranteed the Senior Credit Facility.		7,814		7,514
	Vendor Term Notes: Loans payable to vendors with rates ranging from 6% to 4.5% and maturing dates of November 2014 and May 2015.		1,013		-
	Capital Lease Obligations: Capital leases with rates ranging from 10.13% to 13.21% and maturing dates ranging from February 2014 to October 2016.		2,437		2,019
	Direct Stockholder Loans – extinguished in 2014		-		44,721
	Subordinated Bank Debt – extinguished in 2014		-		28,041
	Total		22,029		98,073
	Less current portion		-13,017		-75,422
	Long-term debt	$	9,012	$	22,651

WARRANTS_COMMON_STOCK_PUT_AGRE1

WARRANTS, COMMON STOCK PUT AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
	A summary of the status of the warrants issued by the Company as of September 30, 2014, and changes during the nine months then ended is presented below:
				Weighted
				Average
		Shares		Exercise Price
	Outstanding, December 31, 2013		-	$	-
	Granted		80,592,105	$	0.76
	Canceled / Expired		-	$	-
	Exercised		-	$	-
	Outstanding, September 30, 2014		80,592,105	$	0.76

NATURE_OF_OPERATIONS_AND_SUMMA3

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Mexico [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	$1,072	$1,314
Mexico [Member] | Sales Revenue, Net [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Concentration Risk, Percentage	2.28%	2.29%
Canada [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	1,966	1,213
Canada [Member] | Sales Revenue, Net [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Concentration Risk, Percentage	4.17%	2.12%
Other Geographical [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	$4,767	$9,658
Other Geographical [Member] | Sales Revenue, Net [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Concentration Risk, Percentage	10.11%	16.86%

NATURE_OF_OPERATIONS_AND_SUMMA4

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) (Fair Value, Measurements, Recurring [Member], USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	$38	$60
Marketable Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	38	60
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	38	60
Fair Value, Inputs, Level 1 [Member] | Marketable Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	38	60
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member] | Marketable Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 3 [Member] | Marketable Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value Disclosure	$0	$0

NATURE_OF_OPERATIONS_AND_SUMMA5

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual)	9 Months Ended					12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Dec. 31, 2013
	Sales Revenue, Net [Member]	Sales Revenue, Net [Member]	Sales Revenue, Net [Member]	Sales Revenue, Net [Member]	Accounts Receivable [Member]	Accounts Receivable [Member]
	Top Three Major Customers [Member]	Top Three Major Customers [Member]	Customer One [Member]	Customer One [Member]
Concentration Risk [Line Items]	'	'	'	'	'	'
Concentration Risk, Percentage	27.80%	30.30%	13.90%	15.30%	28.00%	27.00%

GOING_CONCERN_Details_Textual

GOING CONCERN (Details Textual) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Going Concern [Line Items]	'	'
Retained Earnings (Accumulated Deficit)	($180,294)	($166,248)
Stockholders' Equity Attributable to Parent	-853	-75,935
Working Capital Deficiency	$2,863	'

MERGER_Details_Textual

MERGER (Details Textual)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014
			Restricted Common Stock [Member]	TCC [Member]
Business Acquisition [Line Items]	'	'	'	'
Stock Issued During Period, Shares, Acquisitions	'	'	199,995,000	'
Business Acquisition, Percentage of Voting Interests Acquired	'	'	'	100.00%
Common Stock, Shares, Issued	220,000,000	200,000,000	'	'
Common Stock, Shares, Outstanding	220,000,000	200,000,000	'	'

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory [Line Items]	'	'
Raw materials	$4,571	$5,302
Work in process	1,598	2,023
Finished goods	8,285	9,191
Inventory, Gross	14,454	16,516
Reserve for obsolete inventory	-1,521	-1,672
Inventory, Net	$12,933	$14,844

PROPERTY_AND_EQUIPMENT_Details

PROPERTY AND EQUIPMENT (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	$21,466	$21,292
Accumulated depreciation and amortization	-16,747	-16,252
Property, Plant and Equipment, Net	4,719	5,040
Machinery and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	10,013	10,007
Computer And Other [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	6,506	6,339
Land [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	577	577
Aquifer [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	2,855	2,855
Leasehold Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	$1,515	$1,514

PROPERTY_AND_EQUIPMENT_Details1

PROPERTY AND EQUIPMENT (Details Textual) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Dec. 31, 2013
					Property, Plant and Equipment [Member]	Property, Plant and Equipment [Member]	Machinery and Equipment [Member]	Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]	'	'	'	'	'	'	'	'
Capital Leased Assets, Gross	'	'	'	'	'	'	$2,437	$2,019
Depreciation, Depletion and Amortization	$114	$228	$1,071	$1,303	$495	$692	'	'

INTANGIBLE_ASSETS_Details

INTANGIBLE ASSETS (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Gross	$11,966	$11,966
Accumulated amortization	-4,285	-3,934
Finite-Lived Intangible Assets, Net	7,681	8,032
Trademarks [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Gross	10,142	10,142
Customer Relationships [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Gross	$1,824	$1,824

INTANGIBLE_ASSETS_Details_Text

INTANGIBLE ASSETS (Details Textual) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Amortization of Intangible Assets	$127	$216	$351	$325
Trademarks [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Asset, Useful Life	'	'	'30 years	'
Customer Relationships [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Asset, Useful Life	'	'	'16 years	'

LONGTERM_DEBT_Details

LONG-TERM DEBT (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'	'
Capital Lease Obligations: Capital leases with rates ranging from 10.13% to 13.21% and maturing dates ranging from February 2014 to October 2016.	$2,437	$2,019
Total	22,029	98,073
Less current portion	-13,017	-75,422
Long-term debt	9,012	22,651
Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term Debt, Gross	7,814	7,514
Unsecured Debt [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term Debt, Gross	10,765	15,778
Subordinated Debt [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term Debt, Gross	0	28,041
Vendor Term Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term Debt, Gross	1,013	0
Direct Stockholder Loans [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term Debt, Gross	$0	$44,721

LONGTERM_DEBT_Details_Textual

LONG-TERM DEBT (Details Textual) (USD $)

9 Months Ended

0 Months Ended

1 Months Ended

9 Months Ended

9 Months Ended

0 Months Ended

In Thousands, except Share data, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 03, 2014

Sep. 05, 2014

Aug. 15, 2014

1-May-14

Jul. 31, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 05, 2014

Maximum [Member]

Minimum [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Unsecured Convertible Promissory Note [Member]

Unsecured Convertible Promissory Note [Member]

Unsecured Convertible Promissory Note [Member]

Unsecured Convertible Promissory Note [Member]

Debt Repayment Agreement [Member]

Unsecured Related Party Debt [Member]

Unsecured Related Party Debt [Member]

Capital Lease Obligations [Member]

Capital Lease Obligations [Member]

Unsecured Convertible Promissory Note1 [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Maximum [Member]

Minimum [Member]

Related Party [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

$15,000

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Gross

'

'

7,814

7,514

2,800

'

3,200

3,000

'

10,765

15,778

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

6.00%

4.50%

'

6.25%

10.00%

'

10.00%

10.00%

'

8.00%

2.25%

13.21%

10.13%

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

1,477,833

'

'

7,000

'

'

'

'

3,684,211

Debt Instrument, Periodic Payment

'

'

'

'

'

'

'

'

4,900

'

'

'

'

'

Debt Instrument Periodic Payment, Termination, Description

'

'

'

'

'

'

'

'

'terminate at such earlier time as the trailing ninety day volume weighted average closing sales price of the Company on all domestic securities exchanges on which it is listed equals or exceeds $5.06 per share.

'

'

'

'

'

Debt Conversion, Original Debt, Amount

'

'

'

'

'

'

'

'

90,000

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

31-Jan-15

'

31-Jan-15

31-Jan-15

'

31-Dec-17

'

'

'

'

Debt Instrument Maturity Date Period

'November 2014

'May 2015

'

'

'

'

'

'

'

'

'

'October 2016

'February 2014

'

Debt Instrument, Description of Variable Rate Basis

'

'

'LIBOR

'

'

'

'

'

'

'LIBOR

'

'

'

'

Debt Instrument, Basis Spread on Variable Rate

'

'

6.00%

'

'

'

'

'

'

2.00%

'

'

'

'

Line of Credit Facility, Commitment Fee Percentage

'

'

0.75%

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Collateral Fee

'

'

'

'

'

'

'

'

'

$150

'

'

'

'

STOCKHOLDERS_DEFICIT_Details_T

STOCKHOLDERS' DEFICIT (Details Textual) (USD $)

0 Months Ended

1 Months Ended

9 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

Sep. 16, 2014

Aug. 28, 2014

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 16, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Notes Receivable [Member]

Chief Executive Officer [Member]

TCC [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Prior To Forward Split [Member]

TCC [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

'

'

5,000,000,000

'

5,000,000,000

'

'

'

'

'

'

100,000,000

Preferred Stock, Shares Authorized

'

'

500,000,000

'

500,000,000

'

'

'

'

'

'

10,000,000

Stockholders' Equity Note, Stock Split, Conversion Ratio

'

50

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

20,000,000

'

'

Share Price

'

'

'

'

'

'

'

'

'

$0.00

'

'

Proceeds from Issuance of Common Stock

'

'

$40,000

$0

'

'

'

'

'

'

'

'

Common Stock, Shares, Outstanding

'

'

220,000,000

'

200,000,000

'

'

'

'

'

'

4,400,000

Common Stock, Shares, Issued

'

'

220,000,000

'

200,000,000

'

'

'

'

'

'

4,400,000

Stock Issued During Period, Shares, Acquisitions

'

'

'

'

'

'

'

'

'

'

199,995,000

'

Business Acquisition, Percentage of Voting Interests Acquired

'

'

'

'

'

'

'

100.00%

'

'

'

'

Stock Repurchased During Period, Shares

'

'

'

'

'

'

'

'

199,995,000

'

'

'

Stock Repurchased During Period, Value

8,000

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Decrease, Forgiveness

7,000

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument Decrease Forgiveness, Accrued Interest

300

'

'

'

'

'

'

'

'

'

'

'

Subscription And Surrender Agreement Shares

'

'

'

'

'

'

65,306,102

'

'

'

'

'

Contingent Agreement Common Stock To Be Acquired

'

'

'

'

'

'

5,021,834

'

'

'

'

'

Common Stock, Share Subscribed but Unissued, Subscriptions Receivable

'

'

300,000

'

0

'

200,000

'

'

'

'

'

Promissory Notes Exchange for Common Stock

'

'

$100,000

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate During Period

'

'

'

'

'

5.00%

'

'

'

'

'

'

WARRANTS_COMMON_STOCK_PUT_AGRE2

WARRANTS, COMMON STOCK PUT AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (Details) (Warrant [Member], USD $)	9 Months Ended
	Sep. 30, 2014
Warrant [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding, December 31, 2013	0
Granted	80,592,105
Canceled / Expired	0
Exercised	0
Outstanding	80,592,105
Options, Outstanding, Weighted Average Exercise Price	$0
Grants in Period, Weighted Average Exercise Price	$0.76
Canceled / Expired, Weighted Average Exercise Price	$0
Exercised, Weighted Average Exercise Price	$0
Outstanding, Weighted Average Exercise Price	$0.76

WARRANTS_COMMON_STOCK_PUT_AGRE3

WARRANTS, COMMON STOCK PUT AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (Details Textual) (USD $)	9 Months Ended
	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.76
Warrant [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock Issued During Period, Shares, Issued for Services	5,592,105
Series A Warrant [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.76
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	52,631,579
Sale of Stock, Price Per Share	0.775
Series A Warrant [Member] | Minimum [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1,461,988
Series B Warrant [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.76
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	22,368,421

OPTION_AGREEMENTS_Details_Text

OPTION AGREEMENTS (Details Textual) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Option No.1 [Member]	'
Business Acquisition [Line Items]	'
Payments to Acquire Businesses, Gross	$2,000
Business Combination, Consideration Transferred	37,000
Option No.2 [Member]	'
Business Acquisition [Line Items]	'
Payments to Acquire Businesses, Gross	350
Business Combination, Consideration Transferred	10,500
Grantor Break-up Fees	$400

SUBSEQUENT_EVENTS_Details_Text

SUBSEQUENT EVENTS (Details Textual) (USD $)	9 Months Ended			9 Months Ended			1 Months Ended	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Nov. 13, 2014	Nov. 13, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
			Penta [Member]	Deferred Draw Note [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
			Scenario, Forecast [Member]	Penta [Member]			Penta [Member]	Penta [Member]	Initial Note [Member]	Deferred Draw Note [Member]	Deferred Warrant [Member]
									Penta [Member]	Penta [Member]	Penta [Member]
Subsequent Event [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	'	'	'	'	4,091,122	'	'	'	'	'	4,960,740
Sale of Stock, Price Per Share	'	'	'	'	'	'	$0.01	'	'	'	'
Stock Subscriptions Receivable Received	'	'	'	'	$200	'	'	'	'	'	'
Business Combination, Consideration Transferred	'	'	'	'	'	'	'	'	8,000	'	'
Common Stock, Par or Stated Value Per Share	$0.00	$0.00	'	'	'	'	'	$0.00	'	'	'
Debt Instrument, Payment Terms	'	'	'	'(i) $90 per quarter for the first four quarters, (ii) $110 per quarter for the next four quarters and (iii) $130 per quarter for each quarter thereafter and (b) the first interest payment date is as of this date undeterminable.	'	'	'	'	'(i) $360 per quarter for the first four quarters, (ii) $440 per quarter for the next for quarters and (iii) $520 per quarter for each quarter thereafter.	'	'
Debt Instrument, Interest Rate During Period	'	'	'	'	'	'	'	'	12.00%	'	'
Debt Instrument, Interest Rate, Increase (Decrease)	'	'	'	'	'	'	'	'	18.00%	'	'
Debt Instruments Prepayment Terms	'	'	'	'	'	'	'	'	'Amounts outstanding under the Initial Note may be prepaid, in whole or in part at any time, with prepayment fees ranging from three percent (3%) to one percent (1%) depending on when the prepayment is made.	'	'
Debt Instrument, Fee Amount	'	'	'	'	'	'	'	'	160	40	'
Business Acquisition, Planned Restructuring Activities, Description	'	'	'	'	'	'	'	'(i) furnishing of reports and financial information; (ii) obtaining key-person life insurance on the life of the chief executive officer and/or president of the Twinlab Companies; (iii) electing a representative of Penta to serve on the Board of Directors of the Company until the earlier of (x) the date on which less than $5,000 of principal remains outstanding under the Notes or (y) the date on which the Company has a market cap of $400,000 or more and EBITDA (as defined in the Purchase Agreement) for the four fiscal quarters then ending of greater than or equal to $20,000, (iv) meeting certain financial tests as to the Minimum Adjusted EBITDA, Fixed Charge Coverage Ratio and Total Funded Debt to Adjusted EBITDA Ratio, all as defined in the Purchase Agreement; (v) restrictions on certain mergers, consolidations, asset sales and acquisitions; (vi) restrictions on the making of capital expenditures in any fiscal year in excess of $2,500; (vii) restrictions on the making of dividends; (viii) restrictions on incurring indebtedness and (ix) restrictions on certain asset dispositions.	'	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	'	'	'	'	'	'	4,091,122	'	'	'	'
Adjusted EBITDA Limit	'	'	19,250	'	'	'	'	'	'	'	'
Debt Instrument, Interest Rate, Effective Percentage Rate Range, Maximum	'	'	'	'	'	'	'	'	15.00%	'	'
Equity, Fair Value Disclosure	'	'	'	'	'	'	'	3,750	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	'	'	'	15,000	'	'	'	'	'
Line of Credit Facility, Current Borrowing Capacity	'	'	'	'	'	9,500	'	'	'	'	'
Sale Leaseback Transaction, Gross Proceeds, Investing Activities	'	'	'	'	2,500	'	'	'	'	'	'
Sale Leaseback Transaction Sale Reserve	'	'	'	'	1,250	'	'	'	'	'	'
Amendment fees	$35	'	'	'	$100	'	'	'	'	'	'